Key facts
- Esperto Medical’s last known valuation is $32.0M (Feb 2025).
- It has raised $16.0M; the latest was Later Stage VC ($15.2M) in Feb 2025.
- Notable investors include Maverick Ventures, BOLD Capital Partners, Maverick Capital, Catalyst Health Ventures, Freeflow Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Esperto Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Esperto Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Esperto Medical
Developer of noninvasive continuous blood pressure monitoring technology designed to expand access to accurate vital sign tracking and reduce dependence on cuff-based methods. The company's technology offers calibration-free ultrasound-based resonance measurement, wireless wearable devices, continuous real-time data, and clinically validated accuracy, enabling healthcare professionals, hospitals, patients, researchers, and employers to achieve reliable monitoring, early detection of health changes, and improved medical decision-making.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2018
- Employees
- 10
- Website
- esperto.health/
- Ownership
- Privately Held (backing)
Esperto Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Esperto Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Esperto Medical in its N-PORT filings yet. We sweep new filings monthly.